Lung Cancer Edition: Top Headlines for Week of August 8, 2022

In this edition, lung cancer risk is high among smokers for whom screening is not recommended; the role of circulating tumor DNA in lung cancer detection and treatment is 'exciting' for field; a subset of patients with lung cancer have poor response to COVID-19 vaccines, and more.

Read the full coverage here:

Lung cancer risk high among smokers for whom screening is not recommended

Role of circulating tumor DNA in lung cancer detection, treatment 'exciting' for field

Subset of patients with lung cancer have poor response to COVID-19 vaccines

Low area-level income, education linked to higher odds of late-stage lung cancer diagnosis

Phase 3 trial of Onivyde for small cell lung cancer misses endpoint

References:

Faselis C, et al. JAMA Oncol. 2022;doi:10.1001/jamaoncol.2022.2952.

Gupta A, et al. Cancer. 2022;doi:10.1002/cncr.34327.

Healio Interview

Press Release

Valanparambil RM, et al. J Clin Oncol. 2022;doi:10.1200/JCO.21.02986.